The mechanism underpinning the immunoregulatory effect of stem cell transplantation, particularly CST1-based intervention, will shed light on the development of new therapeutic strategies for curing liver diseases or other diseases that involve IFN over-activation. This evidence concerns the gene CST1 and liver disorder.